| Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients JD Barros-Silva, D Leitao, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, ... British journal of cancer 100 (3), 487-493, 2009 | 224 | 2009 |
| FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer P Paulo, JD Barros‐Silva, FR Ribeiro, J Ramalho‐Carvalho, C Jerónimo, ... Genes, Chromosomes and Cancer 51 (3), 240-249, 2012 | 83 | 2012 |
| Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements P Paulo, FR Ribeiro, J Santos, D Mesquita, M Almeida, JD Barros-Silva, ... Neoplasia 14 (7), 600-IN15, 2012 | 82 | 2012 |
| Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene FR Ribeiro, P Paulo, VL Costa, JD Barros-Silva, J Ramalho-Carvalho, ... PloS one 6 (7), e22317, 2011 | 54 | 2011 |
| Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation A Gusev, H Shi, G Kichaev, M Pomerantz, F Li, HW Long, SA Ingles, ... Nature communications 7 (1), 1-13, 2016 | 43 | 2016 |
| Novel 5′ fusion partners of ETV1 and ETV4 in prostate cancer JD Barros-Silva, P Paulo, AC Bakken, N Cerveira, M Løvf, R Henrique, ... Neoplasia 15 (7), 720-IN6, 2013 | 39 | 2013 |
| Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies J Vieira, R Henrique, FR Ribeiro, JD Barros‐Silva, A Peixoto, C Santos, ... Genes, Chromosomes and Cancer 49 (10), 935-947, 2010 | 39 | 2010 |
| Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations J Ramalho-Carvalho, M Pires, S Lisboa, I Graça, P Rocha, ... PLoS One 8 (3), e58206, 2013 | 38 | 2013 |
| Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing’s sarcoma and prostate carcinoma MJ Camões, P Paulo, FR Ribeiro, JD Barros-Silva, M Almeida, VL Costa, ... PloS one 7 (11), e49819, 2012 | 35 | 2012 |
| Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer JD Barros-Silva, DE Linn, I Steiner, G Guo, A Ali, H Pakula, G Ashton, ... Cell reports 25 (12), 3504-3518. e6, 2018 | 34 | 2018 |
| Relative 8q gain predicts disease‐specific survival irrespective of the TMPRSS2‐ERG fusion status in diagnostic biopsies of prostate cancer JD Barros‐Silva, FR Ribeiro, Â Rodrigues, R Cruz, AT Martins, ... Genes, Chromosomes and Cancer 50 (8), 662-671, 2011 | 33 | 2011 |
| Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution N Cerveira, S Lisboa, C Correia, S Bizarro, J Santos, L Torres, J Vieira, ... Molecular oncology 6 (5), 553-564, 2012 | 26 | 2012 |
| Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts D Mesquita, JD Barros-Silva, J Santos, RI Skotheim, RA Lothe, P Paulo, ... Oncotarget 6 (7), 5217, 2015 | 23 | 2015 |
| Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing T Nome, GOS Thomassen, J Bruun, T Ahlquist, AC Bakken, AM Hoff, ... Translational oncology 6 (5), 546-IN5, 2013 | 22 | 2013 |
| Genomic evaluation of multiparametric magnetic resonance imaging-visible and-nonvisible lesions in clinically localised prostate cancer MA Parry, S Srivastava, A Ali, A Cannistraci, J Antonello, JD Barros-Silva, ... European urology oncology 2 (1), 1-11, 2019 | 21 | 2019 |
| Deregulation of PAX 2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis P Patrício, J Ramalho‐Carvalho, P Costa‐Pinheiro, M Almeida, ... Journal of cellular and molecular medicine 17 (8), 1048-1058, 2013 | 20 | 2013 |
| Prostate cancer prognosis defined by the combined analysis of 8q, PTEN and ERG MP Silva, JD Barros-Silva, E Ersvær, W Kildal, TS Hveem, M Pradhan, ... Translational oncology 9 (6), 575-582, 2016 | 16 | 2016 |
| Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements J Santos, D Mesquita, JD Barros-Silva, C Jerónimo, R Henrique, A Morais, ... Oncoscience 2 (5), 497, 2015 | 12 | 2015 |
| Radiosensitising cancer using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or mammalian target of rapamycin (mTOR) Inhibitors K Wanigasooriya, R Tyler, JD Barros-Silva, Y Sinha, T Ismail, AD Beggs Cancers 12 (5), 1278, 2020 | 10 | 2020 |
| NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer MP Silva, JD Barros‐Silva, J Vieira, S Lisboa, L Torres, C Correia, ... Genes, Chromosomes and Cancer 55 (4), 365-374, 2016 | 9 | 2016 |
Rolf SkotheimDept. Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-RadiumhospitaletEmail verificata su rr-research.no
